We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$571M
AUM Growth
+$64.7M
Cap. Flow
+$77M
Cap. Flow %
13.5%
Top 10 Hldgs %
32.92%
Holding
757
New
120
Increased
159
Reduced
207
Closed
89

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$35.4M
2
STLA icon
Stellantis
STLA
+$22.2M
3
PEP icon
PepsiCo
PEP
+$18M
4
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$6.64M
5
KSS icon
Kohl's
KSS
+$5.18M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$21.5M
2
EIDO icon
iShares MSCI Indonesia ETF
EIDO
+$11.1M
3
ETN icon
Eaton
ETN
+$4.76M
4
DAL icon
Delta Air Lines
DAL
+$4.4M
5
WU icon
Western Union
WU
+$4.14M

Sector Composition

Rank Sector Weight
1 Financials 13.66%
2 Consumer Discretionary 12.98%
3 Consumer Staples 8.41%
4 Energy 8.01%
5 Industrials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
276
Applied Materials
AMAT
$398B
$195K 0.03%
+4,335
New +$183K
DEI icon
277
Douglas Emmett
DEI
$2.02B
$194K 0.03%
+4,866
New +$199K
PGRE
278
DELISTED
Paramount Group
PGRE
$193K 0.03%
+13,778
New +$199K
LSI
279
DELISTED
Life Storage, Inc.
LSI
$193K 0.03%
+3,041
New +$195K
CYBR
280
DELISTED
CyberArk
CYBR
$192K 0.03%
1,500
IOVA icon
281
Iovance Biotherapeutics
IOVA
$2.09B
$191K 0.03%
+7,800
New +$117K
SPLK
282
DELISTED
Splunk Inc
SPLK
$181K 0.03%
1,440
-595
-29% -$75.6K
PTH icon
283
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$225M
$177K 0.03%
6,021
TAP icon
284
Molson Coors Class B
TAP
$7.79B
$174K 0.03%
3,111
+1,087
+54% +$63.5K
GEN icon
285
Gen Digital
GEN
$16.3B
$173K 0.03%
7,961
-46,619
-85% -$1M
GM icon
286
General Motors
GM
$80B
$167K 0.03%
4,336
-1,930
-31% -$72.4K
BKNG icon
287
Booking.com
BKNG
$150B
$167K 0.03%
2,225
+2,125
+2,125% +$153K
DVN icon
288
PUT
Devon Energy
DVN
$50.9B
$163K 0.03%
+2,500
New +$74.3K
CPB icon
289
Campbell Soup
CPB
$6.58B
$162K 0.03%
4,044
-614
-13% -$24.1K
AGNC icon
290
AGNC Investment
AGNC
$12.7B
$157K 0.03%
9,339
-418
-4% -$7.27K
XLNX
291
DELISTED
Xilinx Inc
XLNX
$153K 0.03%
1,299
-129
-9% -$15K
AMGN icon
292
Amgen
AMGN
$209B
$138K 0.02%
+748
New +$134K
JOYY
293
JOYY Inc
JOYY
$3.68B
$135K 0.02%
1,941
-93
-5% -$7.09K
CAR icon
294
Avis
CAR
$5.37B
$132K 0.02%
+3,759
New +$126K
ATVI
295
DELISTED
Activision Blizzard
ATVI
$132K 0.02%
2,791
-6,050
-68% -$278K
BNY
296
Bank of New York Mellon
BNY
$106B
$130K 0.02%
+2,956
New +$139K
MDT icon
297
Medtronic
MDT
$110B
$129K 0.02%
1,328
+1,019
+330% +$93K
LRCX icon
298
Lam Research
LRCX
$372B
$128K 0.02%
6,840
+6,180
+936% +$117K
TWLO icon
299
Twilio
TWLO
$29B
$128K 0.02%
+942
New +$125K
PCG icon
300
PG&E
PCG
$39.2B
$128K 0.02%
5,592
+18
+0.3% +$362

Similar funds

Exane Derivatives's Q2 2019 Portfolio in Review

As of Q2 2019, Exane Derivatives held 757 positions worth $571M, up 13% from $506M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Exane Derivatives deployed $77M of net new capital in Q2 2019, opening 120 new positions and adding to 159 existing holdings. Its largest new stake was Stellantis: 1,528,258 shares worth $21.6M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was iShares MSCI Indonesia ETF, an estimated $11.1M trimmed.

  • Exane Derivatives's largest Q2 2019 buy was Stellantis: 1,528,258 shares worth $21.6M.
  • Exane Derivatives added most to UBS Group in Q2 2019, an estimated $35.4M increase.
  • Exane Derivatives's biggest Q2 2019 reduction was iShares MSCI Indonesia ETF, cutting an estimated $11.1M.
  • Exane Derivatives fully exited Linde in Q2 2019, selling an estimated $21.5M.
  • Exane Derivatives's ten largest holdings make up 33% of its $571M portfolio in Q2 2019.
  • Exane Derivatives opened 120 new positions and closed 89 in Q2 2019.
  • Exane Derivatives's portfolio value rose 13% quarter-over-quarter to $571M.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.